Optimal non-invasive screening strategy for non-alcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
Veeral Ajmera(University of California San Diego), Rohit Loomba(University of California San Diego), Scarlett Lopez(University of California San Diego), Claude B. Sirlin(University of California San Diego), Kathryn J. Fowler(Scripps Clinic Medical Group), Richele Bettencourt(University of California San Diego), Jinho Jung, Lisa Richards(University of California San Diego), Egbert Madamba(University of California San Diego), Keshin Purohit, Sonia Bajwa-Dulai
Cited by 0
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k